A Proposal Mathematical Model for the Vaccine COVID-19 Distribution Network: A Case Study in Mexico

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">No.</td><td class="align_center">Vaccine</td><td class="align_center">Quantity</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">1</td><td class="align_center">Pfizer</td><td class="align_center">13,479,765</td></tr><tr><td class="align_left">2</td><td class="align_center">Sinovac</td><td class="align_center">7,000,000</td></tr><tr><td class="align_left">3</td><td class="align_center">AstraZeneca</td><td class="align_center">6,768,600</td></tr><tr><td class="align_left">4</td><td class="align_center">CanSino</td><td class="align_center">4,645,301</td></tr><tr><td class="align_left">5</td><td class="align_center">Sputnik V</td><td class="align_center">2,400,000</td></tr><tr><td class="align_center" colspan="2">Total</td><td class="align_center">34,293,666</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Total vaccines received in Mexico.</div>

Mathematical Problems in Engineering

tab4

Table 4

Table 4: A Proposal Mathematical Model for the Vaccine COVID-19 Distribution Network: A Case Study in Mexico 